After a strategy revamp Noxopharm is pursuing a clinical program targeting inflammation, notably the painful condition skin lupus.
Here’s the state of play on Wall Street and what it means before the ASX flicks the lights on Wednesday, September 17.
Uranium stocks soared on Tuesday after calls from Trump’s energy tsar to build America’s strategic stockpile. Higher prices will be key.
The US is keen to exploit Greenland’s mineral wealth but its efforts have only showcased the strong progress made by Australian companies.
East Coast Research has initiated cover of Andromeda Metals at 5.4c per share, well above its 1.8c share price.
